Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases.
about
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica.Interleukin-6: a promising target for the treatment of polymyalgia rheumatica or giant cell arteritis?Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab.Current and emerging therapies in large-vessel vasculitis.
P2860
Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Tocilizumab is effective again ...... ience in 13 intractable cases.
@ast
Tocilizumab is effective again ...... ience in 13 intractable cases.
@en
type
label
Tocilizumab is effective again ...... ience in 13 intractable cases.
@ast
Tocilizumab is effective again ...... ience in 13 intractable cases.
@en
prefLabel
Tocilizumab is effective again ...... ience in 13 intractable cases.
@ast
Tocilizumab is effective again ...... ience in 13 intractable cases.
@en
P2093
P2860
P1433
P1476
Tocilizumab is effective again ...... rience in 13 intractable cases
@en
P2093
Harumi Kuda
Hisaji Oshima
Keisuke Izumi
Mari Ushikubo
Masataka Kuwana
P2860
P304
P356
10.1136/RMDOPEN-2015-000162
P577
2015-11-27T00:00:00Z